McKesson (MCK) Tops Q4 EPS by 1c; beats on guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
McKesson shares surge as guidance, long-term targets impress
May 9, 2023 11:52 AM EDT(Updated - May 9, 2023 11:57 AM EDT)
Shares of McKesson, a health services company and pharmaceutical distributor, climbed Tuesday, surging by the most in over three years after it reported earnings and guidance that topped consensus.
Revenue for its fiscal fourth quarter climbed 4% to $68.9 billion and adjusted EPS was up 23% to $7.19. Both beat consensus estimates. It also issued 2024 guidance that beat Wall Street... More



